Home › Funds › Krensavage Asset Management, LLC › VNDA

Krensavage Asset Management, LLC position in VNDA

VANDA PHARMACEUTICALS INC · Health Care

Krensavage Asset Management, LLC reported holding 1,180,388 shares of VNDA (VANDA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$7.2M, representing 2.74% of its reported portfolio and ranking #10 among its reported holdings. Krensavage Asset Management, LLC has disclosed VNDA holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.18M sh
Reported value held$7.22M
Portfolio Weight2.74%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Krensavage Asset Management, LLC's VNDA position evolved

Krensavage Asset Management, LLC first disclosed a stake in VNDA in Q3 2023 at 360,429 shares (US$1.6M). The position peaked in Q4 2025 at 1,180,388 shares, worth US$10.4M. Across 10 filings, Krensavage Asset Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,180,388 shares valued at US$7.2M. Notable position changes include a 37% trim in Q3 2024 (shares rose 2% over the following quarter), a 99% increase in Q1 2025 (shares rose 3% over the following quarter), a 36% increase in Q2 2025 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 360.43K $1.56M New
Q2 2024 662.17K $3.74M New
Q3 2024 414.68K $1.95M Reduce
Q4 2024 378.76K $1.81M Reduce
Q1 2025 754.38K $3.46M Add
Q2 2025 1.02M $4.84M Add
Q3 2025 1.18M $5.89M Add
Q4 2025 1.18M $10.41M Hold
Q1 2026 1.18M $8.16M Hold
Q2 2026 1.18M $7.22M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VNDA and 13F data

VNDA (VANDA PHARMACEUTICALS INC) is a Health Care company. 26 other funds we track also report a position in VNDA — the largest reported positions include AIGH Capital Management LLC (US$12.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VNDA

All VNDA fund holders →

FAQ

How long has Krensavage Asset Management, LLC held VNDA?

Krensavage Asset Management, LLC has disclosed VNDA holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Krensavage Asset Management, LLC's current position in VNDA?

As of Q2 2026, Krensavage Asset Management, LLC holds 1.18M shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $7.22M, representing 2.74% of its reported portfolio and ranking #10.

Has Krensavage Asset Management, LLC been buying or selling VNDA?

In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in VNDA. The position peaked in Q4 2025 at 1.18M shares.

Which other funds hold VNDA?

Other major institutional holders of VNDA include AIGH Capital Management LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.